Tanya will be presenting at the Bio Concepts Neuro Resilience Summit 2026 in Australia 🧠✨ on Sat 31 Oct.

In my session, “Beyond the Hazard Zone: Decoding PMDD Through Genetics, the Endocannabinoid System & Neurotransmitter Chaos,” I’ll be unpacking the complex, multifactorial nature of PMDD, moving beyond hormones alone to explore the neurological, genetic and biochemical drivers of symptoms.

This presentation will support practitioners to:

• ✅ Understand PMDD pathophysiology beyond hormone levels, including serotonin withdrawal, GABA resistance and paradoxical allopregnanolone effects

• ✅ Identify genetic vulnerabilities using nutrigenomic testing (including key SNPs such as 5HT1A, GABRA2, FAAH and FKBP5)

• ✅ Recognise the role of the endocannabinoid system in mood, pain, stress response and hormonal health across the menstrual cycle

• ✅ Explore the bidirectional relationship between sleep and PMDD, particularly during the luteal phase

• ✅ Integrate nervous system, hormonal, methylation and metabolic pathways into comprehensive, context driven treatment protocols

I’m looking forward to sharing a system based, clinically practical approach to supporting women with PMDD.